Product Description
BELLAST® L Product Overview
BELLAST® L is an injectable hyaluronic acid (HA) dermal filler designed for treating medium to deep facial wrinkles, particularly effective for areas such as nasolabial folds. Part of the BELLAST® series, it features cross-linked HA of non-animal origin, combined with 3 mg of lidocaine to reduce pain during application. The BELLAST® series leverages High Concentration Cross-Linking (HCXL) Technology, achieving a biocompatible, high-purity filler with controlled viscosity and elasticity. This formulation provides volume enhancement, wrinkle reduction, and a natural-looking finish for patients.
Key Features:
- Hyaluronic Acid Concentration: 20 mg of cross-linked HA
- Lidocaine Content: 3 mg of lidocaine for pain relief
- Cross-Linking Technology: HCXL technology for high cross-linking efficacy
- Packaging: 1.0 ml per syringe, single-use
BELLAST® L Indications for Use
BELLAST® L is designed for medium-to-deep wrinkle correction in the face, offering immediate volume and contouring benefits. It provides long-lasting results for patients experiencing signs of aging and volume loss, particularly in high-movement areas such as the nasolabial folds.
Primary Indications:
- Nasolabial Folds: Reduces the appearance of deep lines running from the nose to the mouth.
- Marionette Lines: Addresses lines around the mouth for smoother contours.
- Volume Restoration: Enhances facial volume in areas prone to sagging.
- Moderate to Severe Wrinkle Reduction: Suitable for improving moderate to severe facial wrinkles.
BELLAST® L Dosage Information
The application of BELLAST® L involves precise, controlled injections administered by trained practitioners to ensure safe, even distribution in targeted areas.
Treatment Protocols:
- Volume per Injection: 1 ml per session, though the total volume is determined based on the severity of wrinkles and patient goals.
- Injection Depth: Injected into the mid-to-deep dermis, allowing for effective support and volume.
- Frequency of Sessions: Typically requires a single session, with results lasting up to 6 months, although additional touch-up sessions may be recommended based on patient needs and skin condition.
BELLAST® L Side Effects and Precautions
BELLAST® L is well-tolerated, and the lidocaine inclusion minimizes discomfort during injection. As with other dermal fillers, side effects are generally mild and temporary.
Common Side Effects:
- Redness and Swelling: Common at the injection site, usually resolving within 24-48 hours.
- Bruising: Minor bruising may occur, especially in patients with sensitive skin.
- Discomfort or Tenderness: Mild discomfort may be experienced initially, but the lidocaine content generally reduces pain.
Precautions:
- Aseptic Injection Technique: Essential to prevent infections.
- Contraindications: Not suitable for patients with autoimmune diseases, allergies to hyaluronic acid or lidocaine, or active infections at the treatment site.
- Pregnancy and Breastfeeding: Use is not recommended during pregnancy or breastfeeding due to a lack of sufficient safety data.
BELLAST® L Clinical Studies or Real-World Outcomes
Clinical studies on BELLAST® L demonstrate its effectiveness in improving wrinkle severity and volume enhancement. The BELLAST® series has been studied for both efficacy and safety, with positive results in reducing the visibility of nasolabial folds and other moderate-to-severe wrinkles.
Key Findings:
- Wrinkle Severity Reduction: Clinical results show a marked reduction in the Wrinkle Severity Rating Scale (WSRS) after 24 weeks, with improvements comparable to control groups.
- Volume and Density Maintenance: BELLAST® L retains its structure and efficacy for up to 6 months after injection, making it a reliable option for semi-permanent results.
- Patient Satisfaction: Studies indicate a high patient satisfaction rate, with most patients reporting smoother and fuller skin.
Clinical Observations:
- Long-Lasting Effects: Patients observed lasting volume and wrinkle reduction, even in high-mobility areas.
- Safety Profile: Clinical studies documented no serious adverse events, and adverse events observed (such as minor redness or swelling) were mild and resolved without intervention.
BELLAST® L Composition and Active Ingredients
BELLAST® L is formulated with 20 mg of cross-linked hyaluronic acid and 3 mg of lidocaine hydrochloride, leveraging HCXL Technology to create a filler with both high elasticity and viscosity, enhancing cohesiveness and reducing potential migration post-injection.
Key Ingredients:
- Cross-Linked Hyaluronic Acid: Provides volume and elasticity while reducing wrinkles and maintaining hydration.
- Lidocaine (3 mg): Added to minimize pain during and after injection.
- High Concentration Cross-Linking Technology (HCXL): Ensures high cross-linking efficiency, resulting in durable and safe HA hydrogel with minimal cross-linker residue.
BELLAST® L Drug Interactions
Due to its localized application, BELLAST® L has minimal systemic effects, though certain considerations are necessary.
Important Considerations:
- Combination with Other Aesthetic Treatments: May be combined with other fillers or biorevitalization treatments, though spacing injections by at least two weeks is recommended.
- Anticoagulants: Patients on blood-thinning medications should be advised of a slightly increased risk of bruising at the injection sites.
- Immunosuppressive Therapy: Use cautiously in patients on immunosuppressive drugs, as they may be more prone to infection.
